Self-Crosslinked Albumin Nanoparticles for Targeted Doxorubicin Delivery in Glioblastoma.
- DOI
- 10.1021/acs.biomac.6c01684
- Published
- 2026 Nov 9
- Container
- Biomacromolecules
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1021/acs.biomac.6c01684,
title = {Self-Crosslinked Albumin Nanoparticles for Targeted Doxorubicin Delivery in Glioblastoma.},
author = {Naimo GD and Cirillo G and Curcio M and Scorzafave L and Fiore M and Giordano F and Leggio A and Amantea D and Nicoletta FP and Mauro L and Iemma F},
year = {2026},
journal = {Biomacromolecules},
doi = {10.1021/acs.biomac.6c01684},
url = {https://doi.org/10.1021/acs.biomac.6c01684}
}RIS
TY - JOUR TI - Self-Crosslinked Albumin Nanoparticles for Targeted Doxorubicin Delivery in Glioblastoma. AU - Naimo GD AU - Cirillo G AU - Curcio M AU - Scorzafave L AU - Fiore M AU - Giordano F AU - Leggio A AU - Amantea D AU - Nicoletta FP AU - Mauro L AU - Iemma F PY - 2026 JO - Biomacromolecules DO - 10.1021/acs.biomac.6c01684 UR - https://doi.org/10.1021/acs.biomac.6c01684 ER -
APA
GD, N., G, C., M, C., L, S., M, F., F, G., A, L., D, A., FP, N., L, M., & F, I. (2026). Self-Crosslinked Albumin Nanoparticles for Targeted Doxorubicin Delivery in Glioblastoma.. Biomacromolecules. https://doi.org/10.1021/acs.biomac.6c01684
Source records
- pubmed · retrieved 2026-11-10T12:40:18.765Z